Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sebastian Moran

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Molecular Oncology|December 4, 2014
A DNA methylation-based definition of biologically distinct breast cancer subtypesOlafur A Stefansson, Sebastian Moran, Antonio Gomez, et al.
Cell Reports|April 8, 2014
Linkage of DNA methylation quantitative trait loci to human cancer riskHolger Heyn, Sergi Sayols, Catia Moutinho, et al.
Clinical Epigenetics|October 4, 2023
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomasMaría Gallardo-Gómez, Mar Rodríguez-Girondo, Núria Planell, et al.
Cancer Discovery|December 24, 2013
MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1Octavio A Romero, Manuel Torres-Diz, Eva Pros, et al.
International Journal of Obesity (2005)|May 3, 2018
Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysisAna B Crujeiras, Sonsoles Morcillo, Angel Diaz-Lagares, et al.
Carcinogenesis|October 12, 2012
DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarkerHolger Heyn, F Javier Carmona, Antonio Gomez, et al.
Epigenetics|May 19, 2012
Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patientHolger Heyn, Enrique Vidal, Sergi Sayols, et al.
Gastroenterology|August 14, 2016
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional CancerAnna Martínez-Cardús, Sebastian Moran, Eva Musulen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2018
DNA Methylation of <i>LRRC3B</i>: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer PatientsYichen Guo, Ruyang Zhang, Sipeng Shen, et al.
International Journal of Cancer|November 2, 2012
Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancerBodil Øster, Lene Linnet, Lise Lotte Christensen, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Molecular Oncology|December 4, 2014
A DNA methylation-based definition of biologically distinct breast cancer subtypesOlafur A Stefansson, Sebastian Moran, Antonio Gomez, et al.
Cell Reports|April 8, 2014
Linkage of DNA methylation quantitative trait loci to human cancer riskHolger Heyn, Sergi Sayols, Catia Moutinho, et al.
Clinical Epigenetics|October 4, 2023
Serum methylation of GALNT9, UPF3A, WARS, and LDB2 as noninvasive biomarkers for the early detection of colorectal cancer and advanced adenomasMaría Gallardo-Gómez, Mar Rodríguez-Girondo, Núria Planell, et al.
Cancer Discovery|December 24, 2013
MAX inactivation in small cell lung cancer disrupts MYC-SWI/SNF programs and is synthetic lethal with BRG1Octavio A Romero, Manuel Torres-Diz, Eva Pros, et al.
International Journal of Obesity (2005)|May 3, 2018
Identification of an episignature of human colorectal cancer associated with obesity by genome-wide DNA methylation analysisAna B Crujeiras, Sonsoles Morcillo, Angel Diaz-Lagares, et al.
Carcinogenesis|October 12, 2012
DNA methylation profiling in breast cancer discordant identical twins identifies DOK7 as novel epigenetic biomarkerHolger Heyn, F Javier Carmona, Antonio Gomez, et al.
Epigenetics|May 19, 2012
Whole-genome bisulfite DNA sequencing of a DNMT3B mutant patientHolger Heyn, Enrique Vidal, Sergi Sayols, et al.
Gastroenterology|August 14, 2016
Epigenetic Homogeneity Within Colorectal Tumors Predicts Shorter Relapse-Free and Overall Survival Times for Patients With Locoregional CancerAnna Martínez-Cardús, Sebastian Moran, Eva Musulen, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|September 7, 2018
DNA Methylation of <i>LRRC3B</i>: A Biomarker for Survival of Early-Stage Non-Small Cell Lung Cancer PatientsYichen Guo, Ruyang Zhang, Sipeng Shen, et al.
International Journal of Cancer|November 2, 2012
Non-CpG island promoter hypomethylation and miR-149 regulate the expression of SRPX2 in colorectal cancerBodil Øster, Lene Linnet, Lise Lotte Christensen, et al.
Pageof 7